secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2026-09-02T20:47:43+00:00
Accession:  0001493152-26-041250
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SRX Global completes senior secured debt investment in CERo up to $11.67M
-------------------------------------------------------------------------

- Note consolidates prior convertible notes totaling $5,666,108.77; additional advances up to $6,000,000 for $11,666,108.77 max.
- Initial advance of $775,665 funded Aug 27, 2026 for working capital; 10% annual interest (24.99% default).
- Maturity Oct 15, 2026; extendable up to four 30-day periods; secured by CERo subsidiary stock and CER-1236 assets, plus guarantee.
- CER-1236 Phase 1 CERTAIN-T: six patients dosed, no DLTs in latest cohort; third cohort (1B cells/patient) expands to MDS and myelofibrosis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000149315226041250/0001493152-26-041250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000149315226041250/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer